Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Labeling exemptions

This article was originally published in The Tan Sheet

Executive Summary

McNeil asks for additional eight months to comply with OTC labeling final rule for 10-count convenience-size vials of Tylenol Extra Strength and PM in July 24 exemption requests. J&J subsidiary notes additional time may be required if FDA demands changes to proposed wrap-around "Drug Facts" label. Meanwhile, Thursday Plantation expects response to application for exemption from font size restrictions on its 2 oz. Pure Tea Tree Oil product by end of August, Australian firm says Aug. 1. Perrigo also submits multiple exemption requests (1see story, p. 3)

You may also be interested in...



McNeil “Drug Facts” Booklet Pouch Labeling Proposed For Two-Count Sizes

McNeil Consumer Healthcare is requesting a six-month deferral from the OTC labeling final rule requirements to implement "booklet pouch" labeling for two-count sizes of five products

McNeil “Drug Facts” Booklet Pouch Labeling Proposed For Two-Count Sizes

McNeil Consumer Healthcare is requesting a six-month deferral from the OTC labeling final rule requirements to implement "booklet pouch" labeling for two-count sizes of five products

McNeil “Drug Facts” Booklet Pouch Labeling Proposed For Two-Count Sizes

McNeil Consumer Healthcare is requesting a six-month deferral from the OTC labeling final rule requirements to implement "booklet pouch" labeling for two-count sizes of five products

Related Content

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS092875

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel